Study supports wider use of FDA-approved drug for rare muscle disease

UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup